kynuramine has been researched along with inosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodwin, FK; Hirata, F; Marangos, PJ; Patel, J; Paul, SM; Skolnick, P; Sondhein, D | 1 |
| Dong, X; Meng, P; Qin, W; Tan, G; Wang, H; Wu, H; Yuan, J | 1 |
2 other study(ies) available for kynuramine and inosine
| Article | Year |
|---|---|
Inhibition of diazepam binding by tryptophan derivatives including melatonin and its brain metabolite N-acetyl-5-methoxy kynurenamine.
Topics: Animals; Binding, Competitive; Brain; Diazepam; In Vitro Techniques; Inosine; Kinetics; Kynuramine; Melatonin; Propiophenones; Rats; Synaptosomes; Tryptophan | 1981 |
Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
Topics: Biomarkers, Tumor; Case-Control Studies; Demography; Female; Humans; Inosine; Kynuramine; Male; Metabolic Networks and Pathways; Metabolomics; Multivariate Analysis; Neoplasm Grading; Principal Component Analysis; Reproducibility of Results; ROC Curve; Sphingosine; Urinary Bladder Neoplasms | 2017 |